UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
基本信息
- 批准号:10119128
- 负责人:
- 金额:$ 31.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAffectBackBiological AssayBody fatBrown FatCell RespirationCell physiologyCellsCitric Acid CycleClinicalClosure by clampDietDietary InterventionDiseaseEventGoalsHeartHormonalHumanInvestigationKnock-outKnowledgeLaboratoriesLearningMass Spectrum AnalysisMembrane PotentialsMetabolicMetabolic ControlMetabolic PathwayMetabolismMethodsMitochondriaMitochondrial Aspartate AminotransferaseMolecularMouse StrainsMusMuscle MitochondriaNutrientObesityOutcomeOxalacetic AcidOxaloacetatesPharmacologyPhysiologicalPhysiologyProcessProductionProteinsRegulationReportingResearchRespirationRodentRoleServicesSkeletal MuscleSuccinate DehydrogenaseTechnologyTracerTranslatingUniversitiesWorkdesignexperimental studyimprovedketogenic dietlipid metabolismmetabolomicsneglectnoveloverexpressionuncoupling protein 1
项目摘要
PROJECT SUMMARY
Control of metabolic flux through the TCA cycle has been investigated dating back many
decades. However, there are issues that still require clarification. One important, but largely
neglected, issue regards the role of oxaloacetate (OAA) inhibition of succinate dehydrogenase
(SDH) in regulating mitochondrial function. Recent findings in my laboratory focused on skeletal
muscle mitochondria show that while low membrane potential (ΔΨ) drives respiration, low ΔΨ
also initiates a sequence of events leading to mitochondrial OAA accumulation, inhibition of
SDH, and consequent inhibition or metabolic “braking” of respiration. Given that low ΔΨ
appears to be the initiating factor, the current proposal is focused on the role of OAA in
regulating respiration in brown adipose tissue (BAT) wherein ΔΨ is intrinsically low due to the
action of uncoupling protein 1 (UCP1).
Our overall hypothesis is that mitochondrial OAA metabolism and inhibition of SDH is
regulated by definable interactions between UCP1 controlled ΔΨ and downstream events and
that there are physiological consequences. Our aims address three issues. Aim 1 will delineate
molecular events initiated by UCP1-regulated ΔΨ and culminating in OAA inhibition of O2 flux.
Aim 2 examines UCP1 perturbations in live mice to determine if this translates to OAA effects
on mitochondrial and cellular function. Aim 3 attempts to modulate OAA inhibition of SDH in a
way that may prove beneficial towards mitochondrial, cellular, and whole-body metabolism.
To accomplish our objectives, we will use a novel NMR assay to assess mitochondrial
OAA content as well as other metabolites. A major reason why our knowledge of OAA effects
on respiration is lacking is that OAA is difficult to assay since the metabolite is not stable. In fact,
metabolomics services, whether commercial or in university cores, do not offer quantification of
OAA. Our research will also use a novel adaptation of existing technology that we developed to
assess mitochondrial respiration at clamped concentrations of ADP. In this way, we can assess
mitochodnrial respiration beyond the often-determined state 3 and state 4, which are not
physiological states. Finally, we will use up-to-date mass spectroscopy methods for targeted
metabolite expression and for [13C]isotopomer tracer studies directed at metabolic flux.
Our project is applicable to the clinical issue of obesity and its complications since
understanding BAT physiology and how it is regulated will add to our overall knowledge of
whole-body energetics.
项目摘要
通过TCA循环的代谢通量的控制已经被研究,可以追溯到许多年前。
几十年然而,仍有一些问题需要澄清。一个重要的,但很大程度上
草酰乙酸(OAA)抑制琥珀酸脱氢酶的作用被忽视,
(SDH)调节线粒体功能。我的实验室最近的发现集中在骨骼
肌肉线粒体显示,当低膜电位(Δ V)驱动呼吸时,
还启动一系列事件,导致线粒体OAA积累,抑制
SDH,以及随之而来的呼吸抑制或代谢“制动”。考虑到低Δ θ
似乎是引发因素,目前的建议集中于高龄津贴在以下方面的作用:
调节棕色脂肪组织(BAT)中的呼吸,其中由于
解偶联蛋白1(UCP1)。
我们的总体假设是,线粒体OAA代谢和SDH的抑制是
受UCP1控制的Δ Δ β和下游事件之间可定义的相互作用调节,
会有生理后果我们的目标涉及三个问题。目标1将描述
分子事件由UCP1调节的Δ λ启动,并在OAA抑制O2通量中达到高潮。
目的2检查UCP1扰动活小鼠,以确定这是否转化为OAA效应
对线粒体和细胞功能的影响目的3试图调节OAA对SDH的抑制,
这种方式可能被证明对线粒体、细胞和全身代谢有益。
为了实现我们的目标,我们将使用一种新的核磁共振测定来评估线粒体
OAA含量以及其他代谢物。我们对高龄津贴影响的了解
缺乏的是OAA难以测定,因为代谢物不稳定。事实上,
代谢组学服务,无论是商业的还是大学的核心,都不提供代谢组学的定量。
OAA。我们的研究还将使用我们开发的现有技术的新适应,
在ADP的钳制浓度下评估线粒体呼吸。这样,我们就可以评估
线粒体呼吸超出了通常确定的状态3和状态4,而状态3和状态4不是
生理状态。最后,我们将使用最新的质谱方法进行靶向分析。
代谢物表达和针对代谢通量的[13C]同位素异构体示踪剂研究。
我们的项目适用于肥胖及其并发症的临床问题,
了解BAT的生理学以及它是如何调节的,将增加我们对
全身能量学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Irving Sivitz其他文献
William Irving Sivitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Irving Sivitz', 18)}}的其他基金
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
- 批准号:
10263284 - 财政年份:2020
- 资助金额:
$ 31.5万 - 项目类别:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
- 批准号:
10428630 - 财政年份:2020
- 资助金额:
$ 31.5万 - 项目类别:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
- 批准号:
10643873 - 财政年份:2020
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
- 批准号:
8262625 - 财政年份:2010
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
- 批准号:
8195611 - 财政年份:2010
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
- 批准号:
8394599 - 财政年份:2010
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
- 批准号:
7930312 - 财政年份:2010
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
- 批准号:
8974234 - 财政年份:2009
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
- 批准号:
8734547 - 财政年份:2009
- 资助金额:
$ 31.5万 - 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
- 批准号:
8883094 - 财政年份:2009
- 资助金额:
$ 31.5万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NKT cell activation depend on lipid accumulation in adipocytes
NKT 细胞的激活取决于脂肪细胞中的脂质积累
- 批准号:
22K08679 - 财政年份:2022
- 资助金额:
$ 31.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)